Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
The latest announcement is out from Veradigm ( (MDRX) ).
On March 18, 2025, Veradigm announced the appointment of Jonathan Sacks and Bruce Felt as independent directors to its Board, effective March 19, 2025. Lou Silverman will succeed Greg Garrison as Chairman following Garrison’s retirement. These appointments fulfill Veradigm’s obligations under a Cooperation Agreement with Kent Lake PR LLC. The company aims to strengthen its governance and strategic oversight, focusing on remediating internal control deficiencies, executing growth strategies, and relisting its common stock.
More about Veradigm
Veradigm is a healthcare technology company that leverages its platforms, data, expertise, connectivity, and scale to provide advanced insights and data-driven solutions for healthcare providers, payers, and the biopharma market.
YTD Price Performance: -44.84%
Average Trading Volume: 463,895
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $890.1M
Find detailed analytics on MDRX stock on TipRanks’ Stock Analysis page.